Correction to: Mol Neurodegeneration 16, 2 (2021)

https://doi.org/10.1186/s13024-021-00424-9

The original article [1] contains an error in the spelling of Masupirdine.

All instances of ‘Masuperdine’ should thus be considered as ‘Masupirdine’.